Back to News
Market Impact: 0.25
Integra LifeSciences Announces Launch of $600 Million Senior Secured Term Loan B
Source: GlobeNewswire
Credit & Bond MarketsCompany FundamentalsHealthcare & Biotech
Integra LifeSciences proposed a $600 million, seven-year senior secured Term Loan B as part of a broader refinancing transaction. The announcement signals an effort to refinance debt and manage the company’s capital structure, with no pricing, use-of-proceeds breakdown, or operating-financial impact disclosed.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.05
Ticker Sentiment
IART0.35
More News
- Integra LifeSciences cuts 2026 guidance after flooding impact
- Integra LifeSciences Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into Integra LifeSciences (IART)
- Integra LifeSciences lowers revenue and earnings outlook for 2026
- Stock Market Midday, Oct. 2: Stocks Rally as Weak Jobs Data Cools Fed Rate Hike Bets
- The next weak link in Europe’s bond market? UBS has a new short position
- Anthropic warns government attitudes may hurt customer ties, IPO prospectus shows: Reuters